Aon's M&A and Transaction Solutions team in France is delighted to have acted as the transaction insurance adviser to Mars on their acquisition of French veterinary diagnostics businesses Cerba Vet and ANTAGENE from CERBA HEALTHCARE. Cerba Vet is a network of six veterinary diagnostics laboratories in France and Switzerland, which provides full animal-related service diagnostics with complete clinical and anatomic pathology testing as well as endocrinology, microbiology, serology, hematology, chemistry, and other advanced tests, to veterinary practitioners. ANTAGENE is a leading player in animal genetics in Europe, recognised for its expertise in DNA testing for dogs, cats, horses and wildlife. ANTAGENE offers tests globally for diagnosing diseases in pets, as well as supporting scientific initiatives to preserve biodiversity. Cerba Vet and ANTAGENE complement Antech, the veterinary diagnostics business of Mars Science & Diagnostics, which provides a full portfolio of diagnostics solutions to veterinary professionals around the world.
More about the transaction:https://aon.io/3zryWEr
Learn more about Aon's M&A capabilities: https://aon.io/48CebBN
MANAGER at Global Insurance Brokers Private Limited
2dThis initiative marks a significant step towards supporting sustainable energy solutions, ensuring comprehensive risk management for hydrogen projects. It's inspiring to see industry leaders like Aon and Zurich driving positive change in the insurance landscape and contributing to the future of clean energy.